Stay updated on MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.
Latest updates to the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new study on the efficacy and safety of Enclitide Chloride (MK-0616) has been added, replacing the previous study on Enlicitide Decanoate.SummaryDifference2%
- Check19 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe website has added new features for data selection and download options, while several key government health-related URLs have been removed.SummaryDifference14%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links to health-related resources and providing enhanced options for downloading study data in various formats.SummaryDifference17%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
- Check62 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.6%
Stay in the know with updates to MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.